Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
SGLT2 inhibitors activate pantothenate kinase in the human heart.
Journal: Science (New York, N.Y.)
Published: August 27, 2026
Whole body MondoA deletion protects against diet-induced obesity through uncontrolled multi-organ substrate utilization and futile cycling.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Off-target depletion of plasma tryptophan by allosteric inhibitors of BCKDK.
Journal: Molecular metabolism
Published: April 19, 2025
Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension.
Journal: Scientific reports
Published: September 03, 2024
SGLT2 inhibitors activate pantothenate kinase in the human heart.
Journal: bioRxiv : the preprint server for biology
Published: August 02, 2024
SGLT2 Inhibitors Act Independently of SGLT2 to Confer Benefit for HFrEF in Mice.
Journal: Circulation research
Published: July 23, 2024
Two-hit mouse model of heart failure with preserved ejection fraction combining diet-induced obesity and renin-mediated hypertension.
Journal: bioRxiv : the preprint server for biology
Published: June 19, 2024
Sodium-glucose co-transporter 2 Inhibitors Act Independently of SGLT2 to Confer Benefit for Heart Failure with Reduced Ejection Fraction in Mice.
Journal: bioRxiv : the preprint server for biology
Published: May 15, 2024
Off-target depletion of plasma tryptophan by allosteric inhibitors of BCKDK.
Journal: bioRxiv : the preprint server for biology
Published: March 18, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026